BED is characterized by recurrent episodes of binge eatingconsuming unusually large amounts of food within a short periodaccompanied by a sense of loss of control and marked distress, typically without compensatory behaviors such as purging or excessive exercise
In the federal insurance program for the elderly and some disabled persons, Medicare, coverage of GLP-1s for weight loss alone is prohibited, though obese patients can get the semaglutide-based product, Wegovy, covered for heart disease
And full results in clinical trials are measured at 68-72 weeks, not 68-72 days
ColonBroom GLP-1 Booster, on the other hand, is designed with specific herbs and minerals to help regulate blood sugar and appetite for weight loss
Sources: Why Do They Happen
A Closer Look at the GLP-1 Microdosing Trend The popularity of GLP-1 medications has increased rapidly due to broader awareness of their metabolic benefits